<p>Stryker（纽约证券交易所代码：SYK - 获取免费报告）在周六发布的研究报告中被华尔街 Zen 的股票分析师将评级从 “买入” 下调至 “持有”。</p>
<ul>
<li>为什么内部人士正在抛售 Robinhood、Stryker 和 Mercury Systems 的股票？</li>
</ul>
<p>其他几家研究公司最近也对 SYK 发表了评论。Rothschild Redb 在 9 月 18 日的研究报告中将 Stryker 的评级上调至 “持有”。富国银行在 11 月 14 日的研究报告中将 Stryker 的目标价从 452.00 美元上调至 456.00 美元，并给予该公司 “增持” 评级。Truist Financial 在 11 月 14 日的报告中将 Stryker 的目标价从 392.00 美元上调至 400.00 美元，并给予该股票 “持有” 评级。巴克莱在 10 月 22 日的报告中将 Stryker 的目标价从 443.00 美元上调至 453.00 美元，并给予该公司 “增持” 评级。最后，BTIG Research 在 11 月 14 日的报告中重申了 “买入” 评级，并设定了 410.00 美元的目标价。十二位研究分析师对该股票给予了买入评级，六位分析师给予了持有评级。根据 MarketBeat 的数据，Stryker 目前的平均评级为 “适度买入”，共识目标价为 431.83 美元。</p>
<p><strong>查看我们最新的 SYK 股票报告</strong></p>
<h2>Stryker 股票上涨 0.3%</h2>
<ul>
<li>当心死亡交叉：3 只触发这一可怕信号的股票</li>
</ul>
<p>SYK 股票在周五开盘价为 353.99 美元。该股票的 50 日简单移动平均线为 366.81 美元，200 日简单移动平均线为 378.50 美元。该公司的市值为 1353.7 亿美元，市盈率为 46.52，市盈增长比率为 2.50，贝塔值为 0.89。该公司的债务与股本比率为 0.68，速动比率为 1.13，流动比率为 1.85。Stryker 的 52 周低点为 329.16 美元，52 周高点为 406.19 美元。</p>
<p>Stryker（纽约证券交易所代码：SYK - 获取免费报告）最近在 10 月 30 日发布了季度财报。这家医疗技术公司报告本季度每股收益为 3.19 美元，超出市场共识预期的 3.13 美元，超出幅度为 0.06 美元。Stryker 的股本回报率为 24.07%，净利润率为 12.07%。该公司本季度的收入为 60.6 亿美元，而市场共识预期为 60.4 亿美元。去年同期，该公司每股收益为 2.87 美元。该公司的季度收入同比增长 10.2%。Stryker 已将其 2025 财年的指引设定为每股收益 13.500-13.600 美元。研究分析师平均预计 Stryker 在当前财年将发布每股收益 13.47 美元。</p>
<h2>Stryker 的内部买卖</h2>
<ul>
<li>如果你只能持有 3 项投资一生，考虑这些</li>
</ul>
<p>在相关消息中，首席财务官 Preston Wendell Wells 在 11 月 20 日的交易中出售了 165 股公司的股票。股票以平均价格 365.88 美元出售，总价值为 60,370.20 美元。交易后，首席财务官直接持有公司股票 6,694 股，价值约为 2,449,200.72 美元。此次交易使其持股减少了 2.41%。该出售在向证券交易委员会的备案中披露，相关信息可通过此链接访问。此外，首席会计官 William E. Berry, Jr.在 11 月 14 日的交易中出售了 1,953 股公司的股票。该股票以平均价格 365.49 美元出售，总交易额为 713,801.97 美元。出售后，首席会计官持有公司股票 2,833 股，价值 1,035,433.17 美元。此次交易使其持股减少了 40.81%。有关此次出售的更多细节可在官方 SEC 披露中找到。内部人士在上个季度出售了 522,118 股公司股票，价值 185,381,932 美元。当前 5.90% 的股票由公司内部人士持有。</p>
<h2>机构资金流入和流出</h2>
<p>一些机构投资者和对冲基金最近调整了对 SYK 的持股。Mid American Wealth Advisory Group Inc.在第二季度购买了 Stryker 的新头寸，价值约为 26,000 美元。Clayton Financial Group LLC 在第三季度购买了 Stryker 的新股份，价值 26,000 美元。Elevation Point Wealth Partners LLC 在第二季度购买了 Stryker 的新头寸，价值约为 28,000 美元。Sachetta LLC 在第二季度将其在 Stryker 的股份增加了 58.7%。Sachetta LLC 现在持有该医疗技术公司 73 股股票，价值 29,000 美元，此前在该期间内又增持了 27 股。最后，Kilter Group LLC 在第二季度购买了 Stryker 的新股份，价值约为 29,000 美元。77.09% 的股票由机构投资者持有。</p>
<h2>Stryker 公司简介</h2>
<p>（获取免费报告）</p>
<p>Stryker Corporation 是一家医疗技术公司。该公司通过两个部门运营，分别是 MedSurg 和神经技术，以及骨科和脊柱。骨科和脊柱部门提供用于全关节置换（如髋关节、膝关节和肩关节）以及创伤和四肢手术的植入物。</p>
<h2>推荐故事</h2>
<ul>
<li>五只我们更看好的股票超过 Stryker</li>
<li>万亿美元市值的意义超越数字</li>
<li>Synopsys 因 Ansys 整合推动增长而出现看涨转变</li>
<li>寻找并盈利交易 52 周低点的股票</li>
<li>你能给自己最好的假日礼物是什么？Costco 股票</li>
<li>什么是热门股票？热门股票的解释</li>
<li>为什么 Zscaler 股票在 30% 的抛售后可能准备反弹</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVNZSw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVNZSw"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Stryker 吗？</h2>
<p>在你考虑史赛克之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及他们推荐给客户的股票。MarketBeat 已经识别出五只股票，顶级分析师正在悄悄地向他们的客户推荐在更广泛的市场注意到之前购买……而史赛克并不在名单上。</p>
<p>虽然史赛克目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

史赛克

<p>华尔街禅将史赛克（NYSE:SYK）的评级从 “买入” 下调至 “持有”。其他分析师的评级各不相同，有的维持 “买入”，有的则为 “持有”。史赛克的股票共识目标价为 431.83 美元。该公司报告了强劲的季度收益，超出预期，并将 2025 财年的每股收益指引设定在 13.500-13.600。内部人士已开始出售股份，并披露了重大交易。机构投资者最近也调整了他们的持股</p>

<p>Stryker (NYSE:SYK - Get Free Report) was downgraded by stock analysts at Wall Street Zen from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a research report issued on Saturday.</p>
<div class="lb-trans"><p>Stryker（纽约证券交易所代码：SYK - 获取免费报告）在周六发布的研究报告中被华尔街 Zen 的股票分析师将评级从 “买入” 下调至 “持有”。</p>
</div><ul>
<li>Why Are Insiders Are Dumping Shares of Robinhood, Stryker, and Mercury Systems?</li>
</ul>
<div class="lb-trans"><ul>
<li>为什么内部人士正在抛售 Robinhood、Stryker 和 Mercury Systems 的股票？</li>
</ul>
</div><p>Several other research firms also recently commented on SYK. Rothschild Redb raised shares of Stryker to a &#34;hold&#34; rating in a research report on Thursday, September 18th. Wells Fargo &amp; Company lifted their price target on Stryker from $452.00 to $456.00 and gave the company an &#34;overweight&#34; rating in a research note on Friday, November 14th. Truist Financial boosted their price objective on Stryker from $392.00 to $400.00 and gave the stock a &#34;hold&#34; rating in a report on Friday, November 14th. Barclays raised their target price on Stryker from $443.00 to $453.00 and gave the company an &#34;overweight&#34; rating in a report on Wednesday, October 22nd. Finally, BTIG Research reiterated a &#34;buy&#34; rating and set a $410.00 price target on shares of Stryker in a report on Friday, November 14th. Twelve research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company's stock. According to data from MarketBeat, Stryker currently has an average rating of &#34;Moderate Buy&#34; and a consensus target price of $431.83.</p>
<div class="lb-trans"><p>其他几家研究公司最近也对 SYK 发表了评论。Rothschild Redb 在 9 月 18 日的研究报告中将 Stryker 的评级上调至 “持有”。富国银行在 11 月 14 日的研究报告中将 Stryker 的目标价从 452.00 美元上调至 456.00 美元，并给予该公司 “增持” 评级。Truist Financial 在 11 月 14 日的报告中将 Stryker 的目标价从 392.00 美元上调至 400.00 美元，并给予该股票 “持有” 评级。巴克莱在 10 月 22 日的报告中将 Stryker 的目标价从 443.00 美元上调至 453.00 美元，并给予该公司 “增持” 评级。最后，BTIG Research 在 11 月 14 日的报告中重申了 “买入” 评级，并设定了 410.00 美元的目标价。十二位研究分析师对该股票给予了买入评级，六位分析师给予了持有评级。根据 MarketBeat 的数据，Stryker 目前的平均评级为 “适度买入”，共识目标价为 431.83 美元。</p>
</div><p><strong>Check Out Our Latest Stock Report on SYK</strong></p>
<div class="lb-trans"><p><strong>查看我们最新的 SYK 股票报告</strong></p>
</div><h2>Stryker Stock Up 0.3%</h2>
<div class="lb-trans"><h2>Stryker 股票上涨 0.3%</h2>
</div><ul>
<li>Beware the Death Cross: 3 Stocks Triggering This Spooky Signal</li>
</ul>
<div class="lb-trans"><ul>
<li>当心死亡交叉：3 只触发这一可怕信号的股票</li>
</ul>
</div><p>SYK stock opened at $353.99 on Friday. The stock's 50 day simple moving average is $366.81 and its 200 day simple moving average is $378.50. The company has a market cap of $135.37 billion, a P/E ratio of 46.52, a price-to-earnings-growth ratio of 2.50 and a beta of 0.89. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.13 and a current ratio of 1.85. Stryker has a fifty-two week low of $329.16 and a fifty-two week high of $406.19.</p>
<div class="lb-trans"><p>SYK 股票在周五开盘价为 353.99 美元。该股票的 50 日简单移动平均线为 366.81 美元，200 日简单移动平均线为 378.50 美元。该公司的市值为 1353.7 亿美元，市盈率为 46.52，市盈增长比率为 2.50，贝塔值为 0.89。该公司的债务与股本比率为 0.68，速动比率为 1.13，流动比率为 1.85。Stryker 的 52 周低点为 329.16 美元，52 周高点为 406.19 美元。</p>
</div><p>Stryker (NYSE:SYK - Get Free Report) last released its quarterly earnings data on Thursday, October 30th. The medical technology company reported $3.19 EPS for the quarter, beating the consensus estimate of $3.13 by $0.06. Stryker had a return on equity of 24.07% and a net margin of 12.07%.The firm had revenue of $6.06 billion during the quarter, compared to the consensus estimate of $6.04 billion. During the same quarter in the previous year, the company posted $2.87 earnings per share. The company's quarterly revenue was up 10.2% on a year-over-year basis. Stryker has set its FY 2025 guidance at 13.500-13.600 EPS. On average, research analysts expect that Stryker will post 13.47 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>Stryker（纽约证券交易所代码：SYK - 获取免费报告）最近在 10 月 30 日发布了季度财报。这家医疗技术公司报告本季度每股收益为 3.19 美元，超出市场共识预期的 3.13 美元，超出幅度为 0.06 美元。Stryker 的股本回报率为 24.07%，净利润率为 12.07%。该公司本季度的收入为 60.6 亿美元，而市场共识预期为 60.4 亿美元。去年同期，该公司每股收益为 2.87 美元。该公司的季度收入同比增长 10.2%。Stryker 已将其 2025 财年的指引设定为每股收益 13.500-13.600 美元。研究分析师平均预计 Stryker 在当前财年将发布每股收益 13.47 美元。</p>
</div><h2>Insider Buying and Selling at Stryker</h2>
<div class="lb-trans"><h2>Stryker 的内部买卖</h2>
</div><ul>
<li>If You Could Only Hold 3 Investments for Life, Consider These</li>
</ul>
<div class="lb-trans"><ul>
<li>如果你只能持有 3 项投资一生，考虑这些</li>
</ul>
</div><p>In related news, CFO Preston Wendell Wells sold 165 shares of the business's stock in a transaction dated Thursday, November 20th. The shares were sold at an average price of $365.88, for a total value of $60,370.20. Following the transaction, the chief financial officer directly owned 6,694 shares of the company's stock, valued at approximately $2,449,200.72. The trade was a 2.41% decrease in their position. The sale was disclosed in a filing with the Securities &amp; Exchange Commission, which can be accessed through this hyperlink. Also, CAO William E. Berry, Jr. sold 1,953 shares of the firm's stock in a transaction dated Friday, November 14th. The stock was sold at an average price of $365.49, for a total transaction of $713,801.97. Following the sale, the chief accounting officer owned 2,833 shares of the company's stock, valued at $1,035,433.17. This trade represents a 40.81% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 522,118 shares of company stock worth $185,381,932 in the last quarter. 5.90% of the stock is currently owned by company insiders.</p>
<div class="lb-trans"><p>在相关消息中，首席财务官 Preston Wendell Wells 在 11 月 20 日的交易中出售了 165 股公司的股票。股票以平均价格 365.88 美元出售，总价值为 60,370.20 美元。交易后，首席财务官直接持有公司股票 6,694 股，价值约为 2,449,200.72 美元。此次交易使其持股减少了 2.41%。该出售在向证券交易委员会的备案中披露，相关信息可通过此链接访问。此外，首席会计官 William E. Berry, Jr.在 11 月 14 日的交易中出售了 1,953 股公司的股票。该股票以平均价格 365.49 美元出售，总交易额为 713,801.97 美元。出售后，首席会计官持有公司股票 2,833 股，价值 1,035,433.17 美元。此次交易使其持股减少了 40.81%。有关此次出售的更多细节可在官方 SEC 披露中找到。内部人士在上个季度出售了 522,118 股公司股票，价值 185,381,932 美元。当前 5.90% 的股票由公司内部人士持有。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>机构资金流入和流出</h2>
</div><p>A number of institutional investors and hedge funds have recently modified their holdings of SYK. Mid American Wealth Advisory Group Inc. purchased a new position in Stryker in the second quarter valued at approximately $26,000. Clayton Financial Group LLC bought a new stake in shares of Stryker in the third quarter valued at $26,000. Elevation Point Wealth Partners LLC purchased a new position in shares of Stryker during the 2nd quarter valued at $28,000. Sachetta LLC grew its stake in shares of Stryker by 58.7% during the 2nd quarter. Sachetta LLC now owns 73 shares of the medical technology company's stock worth $29,000 after acquiring an additional 27 shares during the period. Finally, Kilter Group LLC purchased a new stake in Stryker in the 2nd quarter worth about $29,000. 77.09% of the stock is owned by institutional investors.</p>
<div class="lb-trans"><p>一些机构投资者和对冲基金最近调整了对 SYK 的持股。Mid American Wealth Advisory Group Inc.在第二季度购买了 Stryker 的新头寸，价值约为 26,000 美元。Clayton Financial Group LLC 在第三季度购买了 Stryker 的新股份，价值 26,000 美元。Elevation Point Wealth Partners LLC 在第二季度购买了 Stryker 的新头寸，价值约为 28,000 美元。Sachetta LLC 在第二季度将其在 Stryker 的股份增加了 58.7%。Sachetta LLC 现在持有该医疗技术公司 73 股股票，价值 29,000 美元，此前在该期间内又增持了 27 股。最后，Kilter Group LLC 在第二季度购买了 Stryker 的新股份，价值约为 29,000 美元。77.09% 的股票由机构投资者持有。</p>
</div><h2>Stryker Company Profile</h2>
<div class="lb-trans"><h2>Stryker 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.</p>
<div class="lb-trans"><p>Stryker Corporation 是一家医疗技术公司。该公司通过两个部门运营，分别是 MedSurg 和神经技术，以及骨科和脊柱。骨科和脊柱部门提供用于全关节置换（如髋关节、膝关节和肩关节）以及创伤和四肢手术的植入物。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推荐故事</h2>
</div><ul>
<li>Five stocks we like better than Stryker</li>
<li>The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number</li>
<li>Synopsys Sees Bullish Shift as Ansys Integration Drives Growth</li>
<li>Find and Profitably Trade Stocks at 52-Week Lows</li>
<li>The Best Holiday Present You Can Give Yourself? Costco Stock</li>
<li>What Are Trending Stocks? Trending Stocks Explained</li>
<li>Why Zscaler Stock Could Be Ready to Bounce After a 30% Selloff</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票超过 Stryker</li>
<li>万亿美元市值的意义超越数字</li>
<li>Synopsys 因 Ansys 整合推动增长而出现看涨转变</li>
<li>寻找并盈利交易 52 周低点的股票</li>
<li>你能给自己最好的假日礼物是什么？Costco 股票</li>
<li>什么是热门股票？热门股票的解释</li>
<li>为什么 Zscaler 股票在 30% 的抛售后可能准备反弹</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVNZSw" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NYSE&amp;Symbol=SYK"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Stryker Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Stryker 吗？</h2>
</div><p>Before you consider Stryker, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑史赛克之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stryker wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及他们推荐给客户的股票。MarketBeat 已经识别出五只股票，顶级分析师正在悄悄地向他们的客户推荐在更广泛的市场注意到之前购买……而史赛克并不在名单上。</p>
</div><p>While Stryker currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然史赛克目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

史赛克（NYSE:SYK）被 Wall Street Zen 下调评级至持有